They Sold Their Company to Boston Scientific and Then Reacquired the Technology Years Later – The Unique Story of NuCryo Vascular

They Sold Their Company to Boston Scientific and Then Reacquired the Technology Years Later – The Unique Story of NuCryo Vascular

vor 10 Jahren
44 Minuten
0
0 0 0
Podcast
Podcaster
Learn from proven medtech and healthtech experts. That's our primary goal with Medsider. Through uncut interviews with the world's brightest thought leaders, you'll pick up on helpful insights, lessons learned, best practices, and much more.

Beschreibung

vor 10 Jahren

Because of diminishing margins, a lot of major medical device
companies continue to add products to their sales bag in hopes of
meeting top-line revenue goals. But selling the entire bag is
challenging. When the bag gets too big, a typical sales force
will usually focus only on products that generate the most
revenue. So what...[read more]


Related Stories


Why Intersect ENT is an Example of Hope for the Medtech
Industry

Are Medical Device Models the Key to Building a Lean Medtech
Startup?

Substantial and Sustainable – 2 Words That Medtech Companies
Should Get Used To 

15
15
Close